Seller record · Telehealth service

Medivive

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 3 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named. The pages refer only to a licensed 503A compounding pharmacy. 2 more criteria also fail; see the table below.

At a glance

MediviveTelehealth service

5/8criteria passed

Price: Not printed before a consultation or sign-up
Sells: compounded semaglutide, compounded tirzepatide, NAD+, and 2 more
FDA letters: None on file

Visit Medivive See all eight dispositions

Telehealth service. Passes 5 of 8 criteria. Recorded against Standard v1.1.

A bilingual telehealth platform that starts with an AI chat and at-home lab testing and prescribes compounded semaglutide and tirzepatide, NAD+ and longevity peptides and hormone therapy through a named telehealth medical group, with no membership fee and no published price.

Operating entity No legal entity name for the company appears in the footer, the terms or the privacy policy, which name it only as Medivive Health; the footer names TrueEval Medical Group PLLC as the medical group.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Medivive's providers page; Medivive's weight page
S2	Prescription gating	PASS	Medivive's weight page
S3	Pharmacy identification	FAIL	Medivive's weight page; Medivive's longevity page
S4	Compounding disclosure	PASS	Medivive's weight page; Medivive's website
S5	Analytical documentation	FAIL	Medivive's weight page; Medivive's longevity page; Medivive's terms
S6	Business address	PASS	Medivive's website; Medivive's terms
S7	Price disclosure	FAIL	Medivive's weight page; Medivive's longevity page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSEvery prescription is signed by a licensed clinician in the patient's state employed by TrueEval Medical Group, and the providers page names its founding nurse practitioner, Shannon M. Smith, MSN, APRN.Source: Medivive's providers page; Medivive's weight page.

S2PASSThe weight program page says starting is free and nothing is paid until a provider reviews the case, and the pricing section says the exact monthly total is shown before anything is charged.Source: Medivive's weight page.

S3FAILNo filling pharmacy is named. The pages refer only to a licensed 503A compounding pharmacy.Source: Medivive's weight page; Medivive's longevity page.

S4PASSThe footer of every page states that compounded medications are not FDA-approved finished drug products and are not reviewed by the FDA, and the weight program page describes the semaglutide and tirzepatide as compounded.Source: Medivive's weight page; Medivive's website.

S5FAILNo certificate of analysis or lot document is published on the weight or longevity pages or in the terms.Source: Medivive's weight page; Medivive's longevity page; Medivive's terms.

S6PASSMedivive Health at 30 N Gould St, Ste R, Sheridan, WY 82801, printed in the footer of every page. The terms name Wyoming law.Source: Medivive's website; Medivive's terms.

S7FAILNo price is printed. The weight and longevity pages say the price is personalized and that the exact all-in monthly total is shown once a provider matches a protocol, with no membership fee.Source: Medivive's weight page; Medivive's longevity page.

S8PASSNo FDA warning letter names Medivive or Medivive Health, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, NAD+, testosterone replacement therapy, hormone replacement therapy.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells NAD+

Visit Medivive

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.